81 related articles for article (PubMed ID: 28340514)
1. Elucidation of the methods used for quantitative analysis of radiolabeled sphingolipids with beta imager 2000 radiochromatoscanner in MOLT-4 leukemic cells.
Venerando B
Int J Cancer; 2017 Jun; 140(12):2831-2832. PubMed ID: 28340514
[No Abstract] [Full Text] [Related]
2. Nucleostemin knocking-down causes cell cycle arrest and apoptosis in human T-cell acute lymphoblastic leukemia MOLT-4 cells via p53 and p21Waf1/Cip1 up-regulation.
Rahmati M; Moosavi MA; Zarghami N
Hematology; 2014 Dec; 19(8):455-62. PubMed ID: 24628257
[TBL] [Abstract][Full Text] [Related]
3. Creation of a human T-ALL cell line online database.
Squiban B; Ahmed ST; Frazer JK
Leuk Lymphoma; 2017 Nov; 58(11):2728-2730. PubMed ID: 28609209
[No Abstract] [Full Text] [Related]
4. Senescent stromal cell-induced divergence and therapeutic resistance in T cell acute lymphoblastic leukemia/lymphoma.
Habiel DM; Krepostman N; Lilly M; Cavassani K; Coelho AL; Shibata T; Elenitoba-Johnson K; Hogaboam CM
Oncotarget; 2016 Dec; 7(50):83514-83529. PubMed ID: 27835864
[TBL] [Abstract][Full Text] [Related]
5. Effects of Vitamin K3 and K5 on Daunorubicin-resistant Human T Lymphoblastoid Leukemia Cells.
Nakaoka E; Tanaka S; Onda K; Sugiyama K; Hirano T
Anticancer Res; 2015 Nov; 35(11):6041-8. PubMed ID: 26504027
[TBL] [Abstract][Full Text] [Related]
6. T-cell lymphoblastic lymphoma of the sternum.
Zareifar S; Bordbar MR; Karimi M; Geramizadeh B; Rasekhi AR
J Clin Oncol; 2010 Feb; 28(4):e51-3. PubMed ID: 19917834
[No Abstract] [Full Text] [Related]
7. CXCR4 Is Required for Leukemia-Initiating Cell Activity in T Cell Acute Lymphoblastic Leukemia.
Passaro D; Irigoyen M; Catherinet C; Gachet S; Da Costa De Jesus C; Lasgi C; Tran Quang C; Ghysdael J
Cancer Cell; 2015 Jun; 27(6):769-79. PubMed ID: 26058076
[TBL] [Abstract][Full Text] [Related]
8. Speed of leukemia development and genetic diversity in xenograft models of T cell acute lymphoblastic leukemia.
Poglio S; Lewandowski D; Calvo J; Caye A; Gros A; Laharanne E; Leblanc T; Landman-Parker J; Baruchel A; Soulier J; Ballerini P; Clappier E; Pflumio F
Oncotarget; 2016 Jul; 7(27):41599-41611. PubMed ID: 27191650
[TBL] [Abstract][Full Text] [Related]
9. [Primary ovarian precursor T-lymphoblastic lymphoma: report of a case].
Liu XY; Zhong SJ; Mi XJ; Chen ZQ; Huang YX; Chen YY
Zhonghua Bing Li Xue Za Zhi; 2012 Dec; 41(12):850-1. PubMed ID: 23324239
[No Abstract] [Full Text] [Related]
10. Plumbagin exerts an immunosuppressive effect on human T-cell acute lymphoblastic leukemia MOLT-4 cells.
Bae KJ; Lee Y; Kim SA; Kim J
Biochem Biophys Res Commun; 2016 Apr; 473(1):272-277. PubMed ID: 27018383
[TBL] [Abstract][Full Text] [Related]
11. AMP-dependent kinase/mammalian target of rapamycin complex 1 signaling in T-cell acute lymphoblastic leukemia: therapeutic implications.
Grimaldi C; Chiarini F; Tabellini G; Ricci F; Tazzari PL; Battistelli M; Falcieri E; Bortul R; Melchionda F; Iacobucci I; Pagliaro P; Martinelli G; Pession A; Barata JT; McCubrey JA; Martelli AM
Leukemia; 2012 Jan; 26(1):91-100. PubMed ID: 21968881
[TBL] [Abstract][Full Text] [Related]
12. Concurrent thymoma, thymic carcinoma, and T lymphoblastic leukemia/lymphoma in an anterior mediastinal mass.
Ito J; Yoshida A; Maeshima AM; Nakagawa K; Watanabe S; Kobayashi Y; Fukuhara S; Tsuta K
Pathol Res Pract; 2015 Sep; 211(9):693-6. PubMed ID: 26150396
[TBL] [Abstract][Full Text] [Related]
13. Promotion of the self-renewal capacity of human acute leukemia cells by Wnt3A.
Kawaguchi-Ihara N; Murohashi I; Nara N; Tohda S
Anticancer Res; 2008; 28(5A):2701-4. PubMed ID: 19035298
[TBL] [Abstract][Full Text] [Related]
14. A new high resolution radioimager for the quantitative analysis of radiolabelled molecules in tissue section.
Laniece P; Charon Y; Cardona A; Pinot L; Maitrejean S; Mastrippolito R; Sandkamp B; Valentin L
J Neurosci Methods; 1998 Dec; 86(1):1-5. PubMed ID: 9894780
[TBL] [Abstract][Full Text] [Related]
15. [Lymphoblastic lymphoma and acute lymphoblastic leukemia: a clinicopathologic, immunophenotypic and prognostic study in 153 Chinese patients].
Pan Y; Li GD; Liu WP; Zhang WY; Tang Y; Li FY
Zhonghua Bing Li Xue Za Zhi; 2009 Dec; 38(12):810-5. PubMed ID: 20193455
[TBL] [Abstract][Full Text] [Related]
16. CD90 and CD110 correlate with cancer stem cell potentials in human T-acute lymphoblastic leukemia cells.
Yamazaki H; Nishida H; Iwata S; Dang NH; Morimoto C
Biochem Biophys Res Commun; 2009 May; 383(2):172-7. PubMed ID: 19341705
[TBL] [Abstract][Full Text] [Related]
17. Targeted inhibition of mTORC1 and mTORC2 by active-site mTOR inhibitors has cytotoxic effects in T-cell acute lymphoblastic leukemia.
Evangelisti C; Ricci F; Tazzari P; Tabellini G; Battistelli M; Falcieri E; Chiarini F; Bortul R; Melchionda F; Pagliaro P; Pession A; McCubrey JA; Martelli AM
Leukemia; 2011 May; 25(5):781-91. PubMed ID: 21331075
[TBL] [Abstract][Full Text] [Related]
18. [Demonstration of leukemic stem cells in the human T-ALLs and study of the involvement of the NOTCH, TAL1 and ERK/MAPK pathways in human T-leukemogenesis].
Gerby B; Armstrong F; Brunet de la Grange P; Calvo J; Ballerini P; Pflumio F
Ann Pathol; 2008 Nov; 28 Spec No 1(1):S28-9. PubMed ID: 18984291
[No Abstract] [Full Text] [Related]
19. Targeted delivery of daunorubicin to T-cell acute lymphoblastic leukemia by aptamer.
Taghdisi SM; Abnous K; Mosaffa F; Behravan J
J Drug Target; 2010 May; 18(4):277-81. PubMed ID: 19943768
[TBL] [Abstract][Full Text] [Related]
20. Triphenotypic acute leukemia with TRAP-positive blasts: A pathological rarity.
Sharma P; Asthana B; Tyagi S
Leuk Res; 2009 Jul; 33(7):e83-4. PubMed ID: 19237193
[No Abstract] [Full Text] [Related]
[Next] [New Search]
